JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web browser. It makes web pages functional for specific purposes and if disabled for some reason, the content or the functionality of the web page can be limited or unavailable.

Thursday, May 8, 2025

Expect more worrisome variants after omicron, scientists say

by

1209 days ago
20220115
FILE - People wait in line at a COVID-19 testing site in Times Square, New York, Monday, Dec. 13, 2021. Scientists are warning that omicron’s lightning-fast spread across the globe practically ensures it won’t be the last worrisome coronavirus variant. And there’s no guarantee the next ones will cause milder illness or that vaccines will work against them. (AP Photo/Seth Wenig, File)

FILE - People wait in line at a COVID-19 testing site in Times Square, New York, Monday, Dec. 13, 2021. Scientists are warning that omicron’s lightning-fast spread across the globe practically ensures it won’t be the last worrisome coronavirus variant. And there’s no guarantee the next ones will cause milder illness or that vaccines will work against them. (AP Photo/Seth Wenig, File)

By LAU­RA UN­GAR-As­so­ci­at­ed Press

 

Get ready to learn more Greek let­ters. Sci­en­tists warn that omi­cron’s whirl­wind ad­vance prac­ti­cal­ly en­sures it won’t be the last ver­sion of the coro­n­avirus to wor­ry the world.

Every in­fec­tion pro­vides a chance for the virus to mu­tate, and omi­cron has an edge over its pre­de­ces­sors: It spreads way faster de­spite emerg­ing on a plan­et with a stronger patch­work of im­mu­ni­ty from vac­cines and pri­or ill­ness.

That means more peo­ple in whom the virus can fur­ther evolve. Ex­perts don’t know what the next vari­ants will look like or how they might shape the pan­dem­ic, but they say there’s no guar­an­tee the se­quels of omi­cron will cause milder ill­ness or that ex­ist­ing vac­cines will work against them.

“The faster omi­cron spreads, the more op­por­tu­ni­ties there are for mu­ta­tion, po­ten­tial­ly lead­ing to more vari­ants,” Leonar­do Mar­tinez, an in­fec­tious dis­ease epi­demi­ol­o­gist at Boston Uni­ver­si­ty, said.

Since it emerged in mid-No­vem­ber, omi­cron has raced across the globe like fire through dry grass. Re­search shows the vari­ant is at least twice as con­ta­gious as delta and at least four times as con­ta­gious as the orig­i­nal ver­sion of the virus.

Omi­cron is more like­ly than delta to re­in­fect in­di­vid­u­als who pre­vi­ous­ly had COVID-19 and to cause “break­through in­fec­tions” in vac­ci­nat­ed peo­ple while al­so at­tack­ing the un­vac­ci­nat­ed. The World Health Or­ga­ni­za­tion re­port­ed a record 15 mil­lion new COVID-19 cas­es for the week of Jan. 3-9, a 55% in­crease from the pre­vi­ous week.

Along with keep­ing com­par­a­tive­ly healthy peo­ple out of work and school, the ease with which the vari­ant spreads in­creas­es the odds the virus will in­fect and linger in­side peo­ple with weak­ened im­mune sys­tems - giv­ing it more time to de­vel­op po­tent mu­ta­tions.

“It’s the longer, per­sis­tent in­fec­tions that seem to be the most like­ly breed­ing grounds for new vari­ants,” said Dr. Stu­art Camp­bell Ray, an in­fec­tious dis­ease ex­pert at Johns Hop­kins Uni­ver­si­ty. “It’s on­ly when you have very wide­spread in­fec­tion that you’re go­ing to pro­vide the op­por­tu­ni­ty for that to oc­cur.”

Be­cause omi­cron ap­pears to cause less se­vere dis­ease than delta, its be­hav­ior has kin­dled hope that it could be the start of a trend that even­tu­al­ly makes the virus milder like a com­mon cold.

It’s a pos­si­bil­i­ty, ex­perts say, giv­en that virus­es don’t spread well if they kill their hosts very quick­ly. But virus­es don’t al­ways get less dead­ly over time.

A vari­ant could al­so achieve its main goal - repli­cat­ing - if in­fect­ed peo­ple de­vel­oped mild symp­toms ini­tial­ly, spread the virus by in­ter­act­ing with oth­ers, then got very sick lat­er, Ray ex­plained by way of ex­am­ple.

“Peo­ple have won­dered whether the virus will evolve to mild­ness. But there’s no par­tic­u­lar rea­son for it to do so,” he said. “I don’t think we can be con­fi­dent that the virus will be­come less lethal over time.”

Get­ting pro­gres­sive­ly bet­ter at evad­ing im­mu­ni­ty helps a virus to sur­vive over the long term. When SARS-CoV-2 first struck, no one was im­mune. But in­fec­tions and vac­cines have con­ferred at least some im­mu­ni­ty to much of the world, so the virus must adapt.

There are many pos­si­ble av­enues for evo­lu­tion. An­i­mals could po­ten­tial­ly in­cu­bate and un­leash new vari­ants. Pet dogs and cats, deer and farm-raised mink are on­ly a few of the an­i­mals vul­ner­a­ble to the virus, which can po­ten­tial­ly mu­tate with­in them and leap back to peo­ple.

An­oth­er po­ten­tial route: With both omi­cron and delta cir­cu­lat­ing, peo­ple may get dou­ble in­fec­tions that could spawn what Ray calls “Franken­vari­ants,” hy­brids with char­ac­ter­is­tics of both types.

When new vari­ants do de­vel­op, sci­en­tists said it’s still very dif­fi­cult to know from ge­net­ic fea­tures which ones might take off. For ex­am­ple, omi­cron has many more mu­ta­tions than pre­vi­ous vari­ants, around 30 in the spike pro­tein that lets it at­tach to hu­man cells. But the so-called IHU vari­ant iden­ti­fied in France and be­ing mon­i­tored by the WHO has 46 mu­ta­tions and doesn’t seem to have spread much at all.

To curb the emer­gence of vari­ants, sci­en­tists stress con­tin­u­ing with pub­lic health mea­sures such as mask­ing and get­ting vac­ci­nat­ed. While omi­cron is bet­ter able to evade im­mu­ni­ty than delta, ex­perts said, vac­cines still of­fer pro­tec­tion and boost­er shots great­ly re­duce se­ri­ous ill­ness, hos­pi­tal­iza­tions and deaths.

Anne Thomas, a 64-year-old IT an­a­lyst in West­er­ly, Rhode Is­land, said she’s ful­ly vac­ci­nat­ed and boost­ed and al­so tries to stay safe by most­ly stay­ing home while her state has one of the high­est COVID-19 case rates in the U.S.

“I have no doubt at all that these virus­es are go­ing to con­tin­ue to mu­tate and we’re go­ing to be deal­ing with this for a very long time,” she said.

Ray likened vac­cines to ar­mor for hu­man­i­ty that great­ly hin­ders vi­ral spread even if it doesn’t com­plete­ly stop it. For a virus that spreads ex­po­nen­tial­ly, he said, “any­thing that curbs trans­mis­sion can have a great ef­fect.” Al­so, when vac­ci­nat­ed peo­ple get sick, Ray said their ill­ness is usu­al­ly milder and clears more quick­ly, leav­ing less time to spawn dan­ger­ous vari­ants.

Ex­perts say the virus won’t be­come en­dem­ic like the flu as long as glob­al vac­ci­na­tion rates are so low. Dur­ing a re­cent press con­fer­ence, WHO Di­rec­tor-Gen­er­al Tedros Ad­hanom Ghe­breye­sus said that pro­tect­ing peo­ple from fu­ture vari­ants — in­clud­ing those that may be ful­ly re­sis­tant to to­day’s shots — de­pends on end­ing glob­al vac­cine in­equity.

Tedros said he’d like to see 70% of peo­ple in every coun­try vac­ci­nat­ed by mid-year. Cur­rent­ly, there are dozens of coun­tries where less than a quar­ter of the pop­u­la­tion is ful­ly vac­ci­nat­ed, ac­cord­ing to Johns Hop­kins Uni­ver­si­ty sta­tis­tics. And in the Unit­ed States, many peo­ple con­tin­ue to re­sist avail­able vac­cines.

“These huge un­vac­ci­nat­ed swaths in the U.S., Africa, Asia, Latin Amer­i­ca and else­where are ba­si­cal­ly vari­ant fac­to­ries,” said Dr. Prab­hat Jha of the Cen­tre for Glob­al Health Re­search at St. Michael’s Hos­pi­tal in Toron­to. “It’s been a colos­sal fail­ure in glob­al lead­er­ship that we have not been able to do this.”

In the mean­time, new vari­ants are in­evitable, said Louis Man­sky, di­rec­tor of the In­sti­tute for Mol­e­c­u­lar Vi­rol­o­gy at the Uni­ver­si­ty of Min­neso­ta.

With so many un­vac­ci­nat­ed peo­ple, he said, “the virus is still kind of in con­trol of what’s go­ing on.

COVID-19Omicron variantOmicron


Related articles

Sponsored

Weather

PORT OF SPAIN WEATHER

Sponsored